Find AMR Resources
Connecting the AMR community with the solutions it needs
The tools advancing the AMR response are as diverse as the problem itself, spanning contract services, diagnostics, surveillance platforms, infection prevention technologies, digital technologies, and beyond. This growing directory brings them together in one place, making it easier for researchers, clinicians, investors, and advocates to find, evaluate, and connect with the solutions the global AMR fight needs.
Rime Bioinformatics is a Trondheim-based Norwegian company providing bioinformatics software and analytical services for genomic analysis of microbial pathogens. Its platforms support whole-genome sequencing workflows for AMR surveillance, outbreak investigation, and resistance gene characterization , providing the computational tools that clinical microbiologists and public health researchers need to analyze, interpret, and act on genomic resistance data.
Roche Diagnostics is the world\'s largest in vitro diagnostics company, providing molecular, microbiology, and point-of-care testing solutions for infectious disease across clinical and laboratory settings globally. Its AMR portfolio includes rapid PCR-based resistance detection, blood culture systems, and antimicrobial susceptibility testing platforms that enable faster, more precise diagnosis of drug-resistant infections , directly supporting antibiotic stewardship and better patient outcomes.
Rostra Therapeutics is a London-based drug discovery company developing S-MGB (Sequence-selective Minor Groove Binding) molecules that kill bacteria, fungi, parasites, and viruses by binding simultaneously to multiple sites on DNA and RNA. This multi-target mechanism of action is inherently difficult for pathogens to evade through resistance, positioning S-MGBs as a potentially resilient platform for new anti-infective therapeutics.
Ryberg is a Dutch company developing innovative solutions for removing pharmaceutical residues and antibiotic compounds from water systems. As a member of the Dutch AMR Consortium, Ryberg applies advanced water treatment technologies , including specialized filtration and purification systems , to prevent antibiotic residues from entering public waterways and contributing to environmental spread of antimicrobial resistance.
BacterOmic delivers complete information on phenotypic antibiotic susceptibility of bacterial pathogens: MIC values for all antibiotics and synergies between up to 20 combinations. It enables precision therapies already after the first test.
Sefunda AG is a Zurich-based life science consulting and business development firm supporting biotech and pharmaceutical companies in strategy, partnering, and market access. It assists AMR-focused innovators in navigating the complex commercial landscape of antibiotic development , providing strategic advisory services on funding, deal structuring, regulatory pathways, and partnership opportunities to advance novel anti-infective programs toward clinical and commercial success.
SINTEF Industry is Norway\'s largest independent research organization, conducting applied research across materials science, chemistry, biotechnology, and health technology. Its biomedical programs include infectious disease diagnostics and novel antimicrobial material development , including work on antimicrobial coatings, wound care materials, and biosensor systems that contribute to the broader AMR toolkit across prevention, diagnosis, and treatment.
Sonix Medical Devices is a US-based medical device company developing ultrasound-based technologies for infection management and wound care. Its devices use focused ultrasound energy to disrupt biofilms and bacterial colonies in infected wounds and implants , addressing one of the most AMR-resistant phenomena in clinical medicine without requiring additional antibiotic treatment, supporting infection clearance in drug-resistant cases.
Standard BioTools is a South San Francisco–based life sciences instruments company providing microfluidics-based platforms for genomics, proteomics, and single-cell analysis. Its Biomark and Juno systems support high-throughput genomic analysis workflows including microbial resistance gene profiling and infectious disease research , providing the precision analytical tools that AMR researchers and clinical microbiologists need for characterizing pathogen populations and resistance mechanisms.
The Signpost is a London-based health communications and media company focused on increasing awareness and understanding of global health challenges including AMR. It develops content, communications strategies, and advocacy materials designed to translate complex scientific and policy information into accessible, compelling narratives for diverse audiences , supporting the public awareness and political engagement that effective AMR responses demand.
TNO is the Netherlands Organisation for Applied Scientific Research, one of Europe\'s largest independent research organizations. Its biomedical and digital health division works on efficient drug development, diagnostics, and health innovation , including research on new antimicrobial therapies and infection prevention technologies. TNO bridges fundamental research and commercial application, supporting both government health policy and industry drug development programs.
Treat Systems is a Rotterdam-based health data company whose TREAT platform harnesses healthcare data to support antimicrobial and diagnostic stewardship. Its software integrates with clinical workflows to help hospitals optimize antibiotic prescribing, track resistance patterns, and implement evidence-based stewardship decisions , delivering real-time intelligence to clinicians managing drug-resistant infections at the point of care.
UC Leuven-Limburg (UCLL) is a Belgian university of applied sciences conducting practice-based research in healthcare, technology, and education. Its research programs include infection prevention and antimicrobial stewardship in nursing and allied health contexts, contributing applied, clinically grounded evidence to AMR management , particularly in non-hospital care settings where stewardship infrastructure is often weakest.
UniQuest is the University of Queensland\'s commercialization company, translating research discoveries , including antimicrobial innovations , into commercial products and partnerships. It manages intellectual property, facilitates licensing agreements, and supports spinout companies emerging from UQ\'s world-leading infectious disease and drug discovery programs, playing a direct role in bringing novel AMR solutions from academic research into clinical and commercial development.
The National Health Laboratory Service is South Africa\'s public health laboratory provider, supplying diagnostic and pathology services to public healthcare facilities nationwide. It trains medical technologists and health professionals and conducts applied infectious disease research. As a frontline provider of antimicrobial susceptibility testing data, NHLS plays a central role in South Africa\'s AMR surveillance and clinical stewardship infrastructure.
The Warwick Antimicrobial Screening Facility is a University of Warwick service providing high-throughput screening and antimicrobial activity testing against a broad panel of clinically relevant resistant bacterial and fungal strains. It supports academic and industry researchers in identifying and validating hit compounds for AMR drug discovery, accelerating early-stage development of new antimicrobial agents targeting WHO priority pathogens.
University Research Corporation (URC) is a Chevy Chase, Maryland–based global health organization implementing health systems strengthening and clinical programs across low- and middle-income countries. Its work includes antimicrobial stewardship, infection prevention, and laboratory capacity building programs in high-AMR-burden regions , supporting the development of the healthcare infrastructure and workforce needed to address drug resistance where its impact is most severe.
Project management and scientific analysis and medical writing/publication
Validé is a Norwegian biotech company developing novel phage-based therapeutics for drug-resistant bacterial infections. Its platform uses bacteriophages , viruses that specifically target and kill bacteria , to treat infections caused by pathogens resistant to conventional antibiotics, with a focus on hard-to-treat hospital-acquired infections for which last-line antibiotics have limited or no remaining efficacy.
Van Remmen is a Dutch manufacturer of UV-C and advanced oxidation process (AOP) systems for water disinfection, purification, and reuse. Its technologies destroy pathogens and pharmaceutical compounds , including antibiotic residues , in water and wastewater streams. The company\'s systems are deployed across healthcare, industrial, and municipal settings as part of AMR mitigation strategies in water management.
Stay connected so that you don't miss the latest AMR insights and updates.
